INVECTYS INC. TO PARTICIPATE IN THE 2021 H.C. WAINWRIGHT 23rd ANNUAL GLOBAL INVESTMENT CONFERENCE SEPTEMBER 13-15, 2021
07 sept. 2021 09h00 HE
|
Invectys, Inc.
Houston, Texas, USA, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Invectys Inc. a clinical-stage immunotherapy company headquartered in Houston and dedicated to the development of a new generation of products...
PD-1 Resistant Head and Neck Cancer (HNC) Market Landscape Report 2021
31 août 2021 04h08 HE
|
Research and Markets
Dublin, Aug. 31, 2021 (GLOBE NEWSWIRE) -- The "PD-1 Resistant Head and Neck Cancer (HNC) - Market Insight, Epidemiology and Market Forecast 2030" report has been added to ResearchAndMarkets.com's...
Global Oncology Based In-Vivo CRO Markets, 2021-2027: Focus on Solid Tumors, Blood Cancer, Other Indications
27 juil. 2021 08h08 HE
|
Research and Markets
Dublin, July 27, 2021 (GLOBE NEWSWIRE) -- The "Oncology Based In-Vivo CRO - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Oncology...
Global $3.32 Bn Interventional Oncology Devices Market to 2030: Embolization Devices, Ablation Devices, & Support Devices
16 juil. 2021 05h53 HE
|
Research and Markets
Dublin, July 16, 2021 (GLOBE NEWSWIRE) -- The "Interventional Oncology Devices Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's...
aTyr Pharma Presents Preclinical Research Highlighting Mechanistic Insights into Tumor Inhibitory Effects of ATYR2810
19 mai 2021 08h00 HE
|
aTyr Pharma, Inc.
SAN DIEGO, May 19, 2021 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological...
Oncology Information System Market by Software, Application and End-user - Global Forecast to 2025
02 mars 2021 07h18 HE
|
Research and Markets
Dublin, March 02, 2021 (GLOBE NEWSWIRE) -- The "Oncology Information System Market by Software (Patient Information System, TPS, RIS, PACS, Services), Application (Medical, Radiation, Surgical...
Global Oncology Bispecific CD3 Molecules Analytical Tool 2021: 67 Companies Plus Partners who are Today Developing 148 Drugs, 127 are in Active Development in Cancer Across 63 Different Targets
26 janv. 2021 04h28 HE
|
Research and Markets
Dublin, Jan. 26, 2021 (GLOBE NEWSWIRE) -- The "Bispecific CD3 Molecules in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.com's offering. There is a considerable and robust...
Immunophotonics Announces First Patient Treated in Clinical Study Evaluating IP-001 in Patients with Advanced Solid Tumors
10 nov. 2020 01h08 HE
|
Immunophotonics, Inc.
ST. LOUIS and BERN, Switzerland, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Immunophotonics, Inc. announces the first patient treated in the phase 1b/2a clinical trial examining IP-001 in thermally ablated...
Immunophotonics Announces Appointment of Jonathan Knowles to Board of Directors
05 oct. 2020 10h13 HE
|
ImmunoPhotonics, Inc.
ST. LOUIS, Oct. 05, 2020 (GLOBE NEWSWIRE) -- Immunophotonics, Inc., a biotechnology company focused on the discovery and development of proprietary immune-activating carbohydrate polymers for the...
Immunophotonics Announces Appointment of Jonathan Knowles to Board of Directors
05 oct. 2020 04h13 HE
|
ImmunoPhotonics, Inc.
BERN, Switzerland, Oct. 05, 2020 (GLOBE NEWSWIRE) -- Immunophotonics, Inc., a biotechnology company focused on the discovery and development of proprietary immune-activating carbohydrate polymers...